Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antipruritics on Dermal Blood Flow Response
NCT04399148Phase 1Completed
- Sponsor
- UZ Leuven
- Start
- Jun 2019
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of desloratadine, aprepitant and ketotifen in pruritus (3 arms), sponsored by UZ Leuven. Primary endpoint: Change in dermal blood flow induced by histamine skin pricks at 1 hour. Started Jun 2019; status: completed.
02
Drugs
desloratadineaprepitantketotifen
03
Conditions
pruritus
Beyond the preview
Go deeper on NCT04399148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04399148.